Focus: Venture capital investors in cleantech and life science companies at all stages.
Investment Type: Venture Capital
Mentions in press and media 20
| Date | Title | Description | Source |
| 29.07.2021 | Rubicon Technology Partners : Completes Sale of Majority Sta... | Rubicon Technology Partners, a private equity firm specializing in enterprise software investments, ... | marketscre... |
| 16.03.2021 | Gores Technology Partners II, Inc. Completes $460 Million In... | BOULDER, Colo.--(BUSINESS WIRE)--Mar 16, 2021-- Gores Technology Partners II, Inc. (the “Company”),... | oaoa.com/n... |
| 15.03.2021 | Reinvent Technology Partners Y Announces Pricing of $850 Mil... | NEW YORK--(BUSINESS WIRE)--Mar 15, 2021-- Reinvent Technology Partners Y (the “Company”) announced ... | oaoa.com/n... |
| 11.03.2021 | Gores Technology Partners II, Inc. Announces Pricing of $400... | BOULDER, Colo.--(BUSINESS WIRE)--Mar 11, 2021-- Gores Technology Partners II, Inc. (the “Company”),... | oaoa.com/n... |
| 14.05.2020 | Rubicon Technology Partners Closes Fund III, at Over $1.25 B... | Rubicon Technology Partners, a Boulder, Colo.-based private equity investor focused on enterprise so... | finsmes.co... |
| 12.04.2017 | Heartland Technology Partners Raises $12M | Heartland Technology Partners, LLC, a global water technology company that develops innovative produ... | citybizlis... |
| 30.06.2015 | Impact Investing Gets Bigger With New $400M Venture Fund | By Anne Field Impact investing funds are definitely growing in stature. Case in point: the cl... | dbl.vc/201... |
| 16.04.2014 | ForSight VISION5 Completes $15M Series C Financing | ForSight VISION5, a Menlo Park, CA-based developer of non-invasive products to replace eye drops and... | finsmes.co... |
| 11.12.2013 | NREL Notes: Cleantech’s New Economics and the U.K.'s Electri... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Investment is down, new capacity i... | xconomy.co... |
| 28.04.2013 | Scioderm Completes $16M Series A Financing | Scioderm, a Raleigh, NC-based developer of novel dermatology therapeutics, completed a $16m Series A... | finsmes.co... |
Show more